Clinical Trials Browser

Phase 2/3 × Myasthenia Gravis × 30 days × Clear all

NCT05265273 2026-03-13

A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis

Phase 2/3 Recruiting

Myasthenia Gravis

NCT06055959 2026-02-27

ziMyG

Phase 2/3 Recruiting

Myasthenia Gravis

NCT06149559 2026-02-27

roMyG

Phase 2/3 Recruiting

Myasthenia Gravis

NCT04833894 2026-02-18

ADAPT Jr

Phase 2/3 Recruiting

Myasthenia Gravis